| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
4 companies
Starr Kevin P is a Director at LRMR, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 12 sales. Those positions are worth an estimated $2.1M at current prices.
Starr Kevin P's largest disclosed position is in LRMR as Director, worth about $2.0M. The recent filings there lean toward selling, a net 136,579 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2017 | CTMX Cytomx Therapeutics, Inc. | 10% Owner | Sell | 28,357 | $16.36 | $463,792.91 | -47.4% | |
| Sep 6, 2016 | EDIT Editas Medicine, Inc. | 10% Owner | Sell | 5,890 | $15.90 | $93,665.73 | -100% | |
| Nov 12, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 75,000 | $103.89 | $7,792,118.26 | -45.2% | |
| Sep 24, 2015 | LRMR Larimar Therapeutics, Inc. | Director | Sell | 136,579 | $43.90 | $5,995,402.77 | -22.1% |